HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew J Karter Selected Research

Chronic Renal Insufficiency

10/2017Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use.
3/2016Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew J Karter Research Topics

Disease

46Type 2 Diabetes Mellitus (MODY)
06/2024 - 04/2003
18Hypoglycemia (Reactive Hypoglycemia)
05/2024 - 04/2010
11Hypertension (High Blood Pressure)
01/2022 - 05/2003
11Insulin Resistance
04/2013 - 08/2002
9Glucose Intolerance
04/2013 - 04/2003
8Dementia (Dementias)
01/2023 - 04/2009
8Stroke (Strokes)
07/2021 - 05/2002
8Diabetes Mellitus
01/2018 - 02/2004
7Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 05/2008
7Chronic Kidney Failure (Chronic Renal Failure)
01/2019 - 05/2002
6Hyperglycemia
03/2024 - 06/2004
6Dyslipidemias (Dyslipidemia)
01/2020 - 02/2004
6Myocardial Infarction
01/2018 - 05/2002
6Heart Failure
03/2016 - 05/2002
6Albuminuria
07/2015 - 06/2004
6Atherosclerosis
04/2013 - 05/2003
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2021 - 03/2018
4Obesity
10/2018 - 12/2005
3Vascular Diseases (Vascular Disease)
01/2019 - 12/2007
3Peripheral Nervous System Diseases (PNS Diseases)
01/2016 - 08/2006
3Coronary Disease (Coronary Heart Disease)
12/2015 - 12/2007
3Diabetic Nephropathies (Diabetic Nephropathy)
07/2010 - 06/2004
2Diabetes Complications
08/2023 - 01/2019
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2023 - 01/2019
2Heart Diseases (Heart Disease)
01/2019 - 01/2019
2Eye Diseases (Eye Disease)
01/2019 - 02/2014
2Prediabetic State (Prediabetes)
10/2018 - 04/2013
2Chronic Renal Insufficiency
10/2017 - 03/2016
2Urinary Incontinence
08/2015 - 12/2013
2Chronic Disease (Chronic Diseases)
12/2014 - 04/2009
2Renal Insufficiency (Renal Failure)
04/2010 - 05/2002
2Hyperlipidemias (Hyperlipidemia)
04/2009 - 05/2008
1Frailty
05/2024
1Infections
01/2023
1Macular Edema
01/2023
1Cataract (Cataracts)
01/2019
1Gestational Diabetes (Gestational Diabetes Mellitus)
10/2018
1Acute Coronary Syndrome
10/2018
1Chronic Pain
08/2015
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
02/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2014
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
02/2014
1Retinal Diseases
01/2014
1Hypercholesterolemia
04/2012
1Morbid Obesity
04/2012
1Disease Progression
01/2012
1Pain (Aches)
12/2010

Drug/Important Bio-Agent (IBA)

28Insulin (Novolin)FDA Link
05/2024 - 04/2003
22Glucose (Dextrose)FDA LinkGeneric
03/2024 - 08/2002
14Hemoglobins (Hemoglobin)IBA
01/2022 - 12/2007
12Hypoglycemic Agents (Hypoglycemics)IBA
01/2023 - 04/2005
10oxidized low density lipoproteinIBA
01/2022 - 05/2003
8Blood Glucose (Blood Sugar)IBA
05/2024 - 01/2006
8LDL CholesterolIBA
01/2020 - 02/2004
7LipidsIBA
01/2018 - 05/2003
5Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2023 - 04/2009
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 12/2015
4Triglycerides (Triacylglycerol)IBA
01/2020 - 06/2004
4CholesterolIBA
12/2015 - 02/2004
3HDL CholesterolIBA
01/2020 - 09/2004
2Insulin SecretagoguesIBA
08/2023 - 03/2016
2Retinaldehyde (Retinal)IBA
01/2023 - 01/2014
2CreatinineIBA
07/2015 - 11/2011
2AlbuminsIBA
07/2015 - 11/2011
2Antidepressive Agents (Antidepressants)IBA
08/2014 - 09/2013
2Lipoproteins (Lipoprotein)IBA
04/2013 - 05/2003
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2012 - 12/2005
2ThiazolidinedionesIBA
07/2010 - 03/2004
2Angiotensin Receptor AntagonistsIBA
08/2006 - 06/2004
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2006 - 06/2004
1Sodium-Glucose Transport ProteinsIBA
06/2024
1Sodium-Glucose Transporter 2 InhibitorsIBA
06/2024
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
06/2024
1Protective AgentsIBA
06/2024
1GoldIBA
01/2024
1Metformin (Glucophage)FDA LinkGeneric
10/2018
1BiguanidesIBA
10/2018
1Protamines (Protamine Sulfate)FDA Link
01/2018
1Isophane Insulin (NPH Insulin)FDA Link
01/2018
1Long-Acting Insulin (Insulin, Long Acting)FDA Link
01/2018
1Human Isophane InsulinFDA Link
01/2018
1Antihypertensive Agents (Antihypertensives)IBA
01/2017
1NAD (NADH)IBA
01/2016
1HDL LipoproteinsIBA
12/2015
1LDL Lipoproteins (beta Lipoproteins)IBA
03/2014
1Complement System Proteins (Complement)IBA
02/2014
1ApolipoproteinsIBA
04/2013
1DiureticsIBA
06/2012
1A 19IBA
04/2012
1Rosiglitazone (Avandia)FDA Link
07/2010
1Pioglitazone (Actos)FDA Link
07/2010
12,4-thiazolidinedione (thiazolidinedione)IBA
07/2010

Therapy/Procedure

21Glycemic Control
08/2023 - 04/2005
12Therapeutics
01/2018 - 06/2004
6Surgical Amputation (Amputations)
01/2019 - 05/2002
3Drug Therapy (Chemotherapy)
12/2014 - 04/2009
1Phacoemulsification
01/2019
1Secondary Prevention
10/2018
1Polypharmacy
08/2015
1Bariatric Surgery
12/2014